NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, "Broadwood†), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company ("STAAR†or the "Company†) (NASDAQ: STAA), today announced that it has published a presentation outlining why stockholders should vote on Broadwood's GREEN Proxy Card "AGAINST†the proposed acquisition of the Company by an affiliate of Alcon Inc. (NYSE: ALC) on the terms announced on August 5, 2025. The 81-pa. ...